Rhys Chan is the Chief Executive Officer of Acuitylab Biosciences, where he leads the company’s strategic direction, operational execution, and international expansion of next-generation diagnostic solutions. With over two decades of industry experience, Rhys has held leadership roles across molecular diagnostics, clinical laboratory management, and regulated medical device manufacturing. He brings deep expertise in Six Sigma process optimization, IVDD-compliant kit production, and operational scaling for precision healthcare delivery. His blend of scientific insight and business acumen drives Acuitylab’s commitment to innovation, quality, and global impact in the diagnostics industry.

Peggy Lam is the Chief Operating Officer of Acuitylab Biosciences, where she leads with nearly two decades of expertise in diagnostics and life sciences. Renowned for her operational acumen and strategic execution, Peggy drives efficiency, scale, and transformation across the company’s scientific and business functions.

Prior to joining Acuitylab in 2024, Peggy served for almost 13 years as Chief Operating Officer in a Hong Kong–based biotechnology firm specializing in DNA-based technologies. There, she played an instrumental role in streamlining operations, scaling innovation pipelines, and aligning multidisciplinary teams to deliver impactful healthcare solutions.

In 2012, she spent over six years as Corporate Manager, helping establish the company’s operational infrastructure during a critical period of expansion.

With a proven track record in business operations and company scaling, Peggy is a cornerstone of Acuitylab’s executive leadership—championing operational excellence and advancing the company’s mission in next-generation diagnostics.

Managing corporate strategy, global partnerships, and growth in precision diagnostics and data-driven healthcare. With 20 years of leadership experience across diverse industries—biotechnology, healthcare, therapeutics, diagnostics, technology, automotive, and finance. Held strategic roles at Tesla, Samsung, Myriad Genetics, and IGM Biosciences. Renowned for linking scientific innovation with commercial success in genetic testing, oncology, and personalized medicine, he earned a Master’s from USC’s Marshall School of Business and a Bachelor’s from SFSU’s College of Business.

Seasoned executive with over 20 years of experience in genetics testing, diagnostics and digital healthcare, driving growth through capital raising, product development, and strategic leadership. Registered Medical Laboratory Technologist (MLT) in Hong Kong. Served as CEO and President in different biotech and medical testing companies.